相关实验视频
Updated: May 22, 2025

07:18
Investigating Intestinal Barrier Breakdown in Living Organoids
Published on: March 26, 2020
10.9K
肠道屏障破坏对急性-慢性肝衰竭的作用
Julian Pohl1, Dimitrios Aretakis1, Frank Tacke1
1Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Seminars in liver disease
|March 13, 2025
概括
肠道功能障碍显著导致急性至慢性肝衰竭 (ACLF),严重的肝病. 准肠肝轴为ACLF管理提供了有前途的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 急性至慢性肝衰竭 (ACLF) 是不补偿性肝硬化症的关键状况,死亡率高.
- 肠道功能障碍越来越被认为是ACLF发展和进展的关键因素.
研究的目的:
- 审查肠肝轴在ACLF病变发生中的作用.
- 突出ACLF中针对肠肝轴的最新进展和治疗策略.
主要方法:
- 对实验和临床证据的文献综述.
- 讨论关键因素:肠道屏障的破坏,失生症和细菌转移.
- 治疗点的探索:FXR激应剂,β-阻断剂,抗生素和益生菌.
主要成果:
- 肠道粘膜屏障的破坏,肠道失调和细菌转移是ACLF系统性炎症的核心原因.
- 针对肠肝轴的治疗干预措施显示出缓解ACLF进展的潜力.
- 了解ACLF病理生理学与其他肝硬化阶段的区别至关重要.
结论:
- 肠道完整性的破坏是ACLF病变的组成部分.
- 准肠肝轴为ACLF提供了新的诊断和治疗途径.
- 进一步的研究可以导致更有效地管理这种严重的肝脏综合征.
更多相关视频
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
106
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
106
Chronic Pancreatitis I: Introduction
59
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
59
Chronic Bowel Disorders: Introduction
375
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
375
Hepatic Drug Clearance: Role of Transporters
31
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
31

